DocGo named a top pick for 2023 at Northland

Northland analyst Michael Latimore named DocGo a top pick for 2023 with an Outperform rating and $15 price target. DocGo provides on-demand, high-quality, low-cost mobile health services where and when customers need them, Latimore tells investors in a research note. The analyst says "myriad additional customer programs and catalysts exist" for fiscal 2023, such as Q1 awards, new federal government opportunities, expansions at Dollar General and large transport deals. He believes DocGo’s customers, such as municipalities, should have "healthy budgets even during a recession."